Niacin receptor agonists, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2007309567 (hide)

Owner Merck & Co., Inc.

Inventors Beresis, Richard T.; Colletti, Steven L.

Agent Spruson & Ferguson

Pub. Number AU-A-2007309567

PCT Pub. Number WO2008/051403

Priority 60/853,221 20.10.06 US

Filing date 16 October 2007

Wipo publication date 2 May 2008

International Classifications

A01N 43/38 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/051403 Priority application(s): WO2008/051403

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007309568-Substituted imidazoles as bombesin receptor subtype-3 modulators

2007309558-Crystal modifications -3- (1H-indol-3-yl) -4- [2- (4-methyl-piperazin-1-yl) - quinazolin-4-yl] -pyrrole-2, 5-dione